IntelliPACE<sup>®️</sup> STRATEGY - Data-Driven and Experience-Refined

IntelliPACE®️ STRATEGY - Data-Driven and Experience-Refined

Sound recruitment strategies that align the target population with high-performing sites

The current hot topic in patient recruitment is to use ‘big data’ from a range of resources to drive strategy. While such data can be valuable in initiating a successful recruitment strategy, the ability to synthesize decades of clinical study experience, collaborative site relationships, and hands-on expertise from medical and operational teams brings a much higher degree of confidence and predictability in recruitment modeling. Without this pragmatic experience and analysis, volumes of data can lead to erroneous conclusions, adding time to your clinical study.


Medpace’s method for developing successful patient recruitment strategies starts with compiling relevant data from a rich multitude of sources, including our proprietary study management system, ClinTrak®. This data provides objective information on the availability of patient populations in a wide variety of indications, as well as the performance of countries and sites across the globe. The ability to compile and objectively analyze these data permit our team to identify sites best suited for each study.

The multitude of resources analyzed ensures Medpace can provide a highly customized, informed recruitment strategy for each study.

Our collective resources include:

  • Global Health Research Platforms: access to public data and private global health research platforms providing information for over 400,000 investigators, across 300,000 studies, and involving more than 135 million patients, to supplement our internal metrics.
  • Clinical Study History: Our proprietary study management system, ClinTrak®, provides years of Investigator start-up, enrollment, and quality performance metrics to enable identification of high-quality, reliable sites
  • Central Laboratories: a global repository of laboratory data drives sound recommendations relative to key inclusion/exclusion criteria to target investigators with the correct patient population
  • Electronic Data Collection: a wealth of information regarding inclusion/exclusion criteria and their effect on enrollment in similar studies can help to inform study design and recruitment
  • Imaging Core Labs: Assists with the identification of investigators in key therapeutic areas with access to specialized equipment and the experience required to conduct some of the most complicated studies currently designed


Patient level data alone can lead to missteps. Without thoughtful interpretation, an abundance of de-identified healthcare data can lead to spurious conclusions. For example, ‘big data’ may point study teams to a specific geographic region, with a large number of patients who, although patients at an institution, are not connected sufficiently to a site investigator that can enroll them. While geographic location can be important, successful recruitment relies heavily on Investigator location, their motivation, resources, and performance. Neither private nor public healthcare data resources convey a complete picture.

As these factors play an important role in recruitment success, experienced team members are key to identifying potential gaps and areas of opportunity for patient enrollment. Medpace has strong relationships with Key Opinion Leaders and Investigators around the world, facilitating patient recruitment strategies that align with high-performing sites. Medpace also has insight into the standard of care and country-specific regulatory and cultural limitations which are critical to inform a sound recruitment strategy.